Thomas Bogenrieder
- Oncology top 2%
- Peptidase Inhibition and Analysis 6
- Cancer-related Molecular Pathways 6
- Cutaneous Melanoma Detection and Management 6
- Immunology and Allergy top 2%
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 6
- Immunology top 10%
- Immunotherapy and Immune Responses 6
- Molecular Biology top 10%
- Melanoma and MAPK Pathways 6
-
- Growth Hormone and Insulin-like Growth Factors 8
-
- Prostate Cancer Treatment and Research 5
- Co-authors
- Meenhard HerlynUlrike Weyer-CzernilofskyKapaettu SatyamoorthyDirk J. RuiterDavid E. ElderAnthony P. AlbinoChristos N. PapandreouCarola Berking
- Journals
- Cancer Research (7 papers)Annals of Oncology (5 papers)Journal of Clinical Oncology (5 papers)
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
Thomas Bogenrieder
60 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 107
- Oncology 1.2k
- Immunology and Allergy 236
- Cancer Research 536
- Immunology 371
- Molecular Biology 1.2k
Countries citing papers authored by Thomas Bogenrieder
This map shows the geographic impact of Thomas Bogenrieder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Bogenrieder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Bogenrieder more than expected).
Fields of papers citing papers by Thomas Bogenrieder
This network shows the impact of papers produced by Thomas Bogenrieder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Bogenrieder. The network helps show where Thomas Bogenrieder may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Bogenrieder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 3 | |
| 2 | 2021 | 9 | |
| 3 | 2021 | 6 | |
| 4 | 2020 | 14 | |
| 5 | 2019 | 38 | |
| 6 | 2018 | 50 | |
| 7 | 2017 | 9 | |
| 8 | 2017 | 125 | |
| 9 | 2017 | 2 | |
| 10 | 2016 | 193 | |
| 11 | 2016 | 2 | |
| 12 | 2015 | 0 | |
| 13 | 2012 | 39 | |
| 14 | 2011 | 6 | |
| 15 | 2003 | 2 | |
| 16 | 2003 | 134 | |
| 17 | 2003 | 8 | |
| 18 | 2003 | 45 | |
| 19 | 1998 | 30 | |
| 20 | 1998 | 0 |
About Thomas Bogenrieder
Thomas Bogenrieder is a scholar working on Oncology, Cancer Research and Immunology and Allergy, having authored 63 papers that have together received 2.6k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (8 papers), Melanoma and MAPK Pathways (6 papers), Peptidase Inhibition and Analysis (6 papers), Immunotherapy and Immune Responses (6 papers), Cancer-related Molecular Pathways (6 papers), Cutaneous Melanoma Detection and Management (6 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Prostate Cancer Treatment and Research (5 papers). The work is most often cited by research in Oncology (1.2k citations), Immunology and Allergy (236 citations) and Cancer Research (536 citations). Thomas Bogenrieder has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Meenhard Herlyn, Ulrike Weyer-Czernilofsky, Kapaettu Satyamoorthy, Dirk J. Ruiter, David E. Elder, Anthony P. Albino, Christos N. Papandreou, Carola Berking, David M. Nanus and Valentine M. Macaulay. Their work appears in journals such as Cancer Research, Annals of Oncology, Journal of Clinical Oncology, Oncogene and Melanoma Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.